GILD logo

Gilead Sciences (GILD) Accounts receivable

Annual accounts receivable:

$4.42B-$240.00M(-5.15%)
December 31, 2024

Summary

  • As of today (May 29, 2025), GILD annual accounts receivable is $4.42 billion, with the most recent change of -$240.00 million (-5.15%) on December 31, 2024.
  • During the last 3 years, GILD annual accounts receivable has fallen by -$73.00 million (-1.62%).
  • GILD annual accounts receivable is now -24.50% below its all-time high of $5.85 billion, reached on December 31, 2015.

Performance

GILD Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDbalance sheet metrics

Quarterly accounts receivable:

$4.39B-$32.00M(-0.72%)
March 1, 2025

Summary

  • As of today (May 29, 2025), GILD quarterly accounts receivable is $4.39 billion, with the most recent change of -$32.00 million (-0.72%) on March 1, 2025.
  • Over the past year, GILD quarterly accounts receivable has dropped by -$281.00 million (-6.02%).
  • GILD quarterly accounts receivable is now -28.80% below its all-time high of $6.16 billion, reached on March 31, 2016.

Performance

GILD Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

GILD Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.2%-6.0%
3 y3 years-1.6%+15.9%
5 y5 years+23.4%+12.3%

GILD Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.5%at low-8.4%+15.9%
5 y5-year-9.7%+23.4%-10.3%+37.4%
alltimeall time-24.5%+8954.8%-28.8%+8889.2%

GILD Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$4.39B(-0.7%)
Dec 2024
$4.42B(-5.2%)
$4.42B(-3.6%)
Sep 2024
-
$4.59B(-1.6%)
Jun 2024
-
$4.66B(-0.1%)
Mar 2024
-
$4.67B(+0.2%)
Dec 2023
$4.66B(-2.4%)
$4.66B(-2.7%)
Sep 2023
-
$4.79B(+13.3%)
Jun 2023
-
$4.23B(+1.6%)
Mar 2023
-
$4.16B(-12.9%)
Dec 2022
$4.78B(+6.3%)
$4.78B(+9.7%)
Sep 2022
-
$4.35B(+5.7%)
Jun 2022
-
$4.12B(+8.7%)
Mar 2022
-
$3.79B(-15.7%)
Dec 2021
$4.49B(-8.2%)
$4.49B(-1.6%)
Sep 2021
-
$4.57B(+10.1%)
Jun 2021
-
$4.15B(+5.7%)
Mar 2021
-
$3.92B(-19.8%)
Dec 2020
$4.89B(+36.6%)
$4.89B(+25.0%)
Sep 2020
-
$3.91B(+22.5%)
Jun 2020
-
$3.19B(-18.2%)
Mar 2020
-
$3.91B(+9.1%)
Dec 2019
$3.58B(+7.7%)
$3.58B(+8.1%)
Sep 2019
-
$3.31B(-2.4%)
Jun 2019
-
$3.40B(+3.4%)
Mar 2019
-
$3.28B(-1.3%)
Dec 2018
$3.33B(-13.6%)
$3.33B(-4.0%)
Sep 2018
-
$3.46B(-2.1%)
Jun 2018
-
$3.54B(-6.2%)
Mar 2018
-
$3.77B(-2.0%)
Dec 2017
$3.85B(-14.7%)
$3.85B(-6.6%)
Sep 2017
-
$4.12B(-7.9%)
Jun 2017
-
$4.48B(+11.0%)
Mar 2017
-
$4.03B(-10.6%)
Dec 2016
$4.51B(-22.9%)
$4.51B(-11.1%)
Sep 2016
-
$5.08B(-11.8%)
Jun 2016
-
$5.75B(-6.7%)
Mar 2016
-
$6.16B(+5.3%)
Dec 2015
$5.85B(+26.3%)
$5.85B(-4.1%)
Sep 2015
-
$6.11B(+14.5%)
Jun 2015
-
$5.33B(+10.3%)
Mar 2015
-
$4.83B(+4.3%)
Dec 2014
$4.63B(+112.4%)
$4.63B(+62.6%)
Sep 2014
-
$2.85B(-17.1%)
Jun 2014
-
$3.44B(+6.2%)
Mar 2014
-
$3.24B(+48.3%)
Dec 2013
$2.18B(+24.6%)
$2.18B(+10.7%)
Sep 2013
-
$1.97B(+4.0%)
Jun 2013
-
$1.90B(-2.5%)
Mar 2013
-
$1.95B(+11.1%)
DateAnnualQuarterly
Dec 2012
$1.75B(-10.2%)
$1.75B(-0.8%)
Sep 2012
-
$1.77B(+3.7%)
Jun 2012
-
$1.70B(-21.3%)
Mar 2012
-
$2.16B(+10.9%)
Dec 2011
$1.95B(+20.3%)
$1.95B(+4.5%)
Sep 2011
-
$1.87B(-3.7%)
Jun 2011
-
$1.94B(+7.6%)
Mar 2011
-
$1.80B(+11.1%)
Dec 2010
$1.62B(+16.7%)
$1.62B(-2.9%)
Sep 2010
-
$1.67B(+12.6%)
Jun 2010
-
$1.48B(-0.6%)
Mar 2010
-
$1.49B(+7.3%)
Dec 2009
$1.39B(+35.8%)
$1.39B(+3.8%)
Sep 2009
-
$1.34B(+7.7%)
Jun 2009
-
$1.24B(+16.4%)
Mar 2009
-
$1.07B(+4.4%)
Dec 2008
$1.02B(+28.7%)
$1.02B(-2.3%)
Sep 2008
-
$1.05B(+2.5%)
Jun 2008
-
$1.02B(+4.2%)
Mar 2008
-
$979.80M(+23.2%)
Dec 2007
$795.13M(+30.5%)
$795.13M(-1.1%)
Sep 2007
-
$803.63M(+9.4%)
Jun 2007
-
$734.51M(+6.1%)
Mar 2007
-
$692.07M(+13.6%)
Dec 2006
$609.32M(+53.8%)
$609.32M(+4.1%)
Sep 2006
-
$585.05M(+19.6%)
Jun 2006
-
$489.32M(+12.8%)
Mar 2006
-
$433.63M(+9.5%)
Dec 2005
$396.13M(+6.7%)
$396.13M(-1.1%)
Sep 2005
-
$400.62M(+7.7%)
Jun 2005
-
$371.98M(-3.5%)
Mar 2005
-
$385.44M(+3.8%)
Dec 2004
$371.25M(+57.8%)
$371.25M(+22.0%)
Sep 2004
-
$304.30M(+9.7%)
Jun 2004
-
$277.31M(+7.7%)
Mar 2004
-
$257.49M(+9.5%)
Dec 2003
$235.22M(+88.1%)
$235.22M(+17.0%)
Sep 2003
-
$201.06M(+0.4%)
Jun 2003
-
$200.31M(+37.2%)
Mar 2003
-
$145.98M(+16.8%)
Dec 2002
$125.04M(+68.4%)
$125.04M(+9.6%)
Sep 2002
-
$114.06M(+12.4%)
Jun 2002
-
$101.46M(+31.9%)
Mar 2002
-
$76.94M(+3.6%)
Dec 2001
$74.23M(+52.1%)
$74.23M(+25.0%)
Sep 2001
-
$59.40M(+9.3%)
Jun 2001
-
$54.35M(+6.2%)
Mar 2001
-
$51.19M(+4.9%)
Dec 2000
$48.81M
$48.81M

FAQ

  • What is Gilead Sciences annual accounts receivable?
  • What is the all time high annual accounts receivable for Gilead Sciences?
  • What is Gilead Sciences annual accounts receivable year-on-year change?
  • What is Gilead Sciences quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Gilead Sciences?
  • What is Gilead Sciences quarterly accounts receivable year-on-year change?

What is Gilead Sciences annual accounts receivable?

The current annual accounts receivable of GILD is $4.42B

What is the all time high annual accounts receivable for Gilead Sciences?

Gilead Sciences all-time high annual accounts receivable is $5.85B

What is Gilead Sciences annual accounts receivable year-on-year change?

Over the past year, GILD annual accounts receivable has changed by -$240.00M (-5.15%)

What is Gilead Sciences quarterly accounts receivable?

The current quarterly accounts receivable of GILD is $4.39B

What is the all time high quarterly accounts receivable for Gilead Sciences?

Gilead Sciences all-time high quarterly accounts receivable is $6.16B

What is Gilead Sciences quarterly accounts receivable year-on-year change?

Over the past year, GILD quarterly accounts receivable has changed by -$281.00M (-6.02%)
On this page